Another novel finding of our study was that the combination of APACHE II score upon admission and D1 percentages of HLA-DR-expressing CD14+ monocytes and PD-L1-expressing CD14+ monocytes could improve the accuracy of predicting IC in patients with AP. The gene discussed is CD14; the disease is alkaline phosphatase measurement.